<DOC>
	<DOCNO>NCT00427284</DOCNO>
	<brief_summary>The aim present study investigate wether endothelial dysfunction associate stable coronary artery disease alter selective aldosterone antagonism Eplerenone potential anti-inflammatory drug versus placebo . Additionally hypothesize selective aldosterone antagonism reduce systemic inflammatory response C-reactive proteine , oxidative stress pro-inflammatory cytokine .</brief_summary>
	<brief_title>Effect Eplerenone Endothelial Function Patients With Stable Coronary Heart Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<criteria>Inclusion criterion : Male patient ( &gt; 30 year age ) history coronary artery disease ( documented coronary angiogram , nuclear imaging , positive stress test ) Stable cardiovascular medication least 4 month Evaluation patient take place Department Internal Medicine , Cardiology , University Hospital Zurich . Exclusion criterion : Evidence myocardial infarction , unstable angina , stroke within 3 month prior study entry coronary intervention/revascularisation procedure within 3 month prior study entry long act nitrate uncontrolled arterial hypertension , define RR &gt; 160/90 mmHg congestive heart failure ( &gt; NYHA I ) Ejection fraction &lt; 50 % AVBlock &gt; IËš creatinine clearance &lt; 50 mL/min insulindependent diabetes mellitus type 2 diabetes microalbuminuria age &lt; 30 year anemia ( Hb &lt; 10 g/dl ) malignancy chronic infection smoke serum potassium &gt; 5.5 meq/L drug abuse potassium supplement potassiumsparing diuretic ( amiloride , spironolactone , triamterene ) concomitant use strong inhibitor CYP450 3A4 ( e.g. , ketoconazole , itraconazole ) know history Cushing disease Morbus Addisons diseases thyroid gland</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Eplerenone auf die Endothelfunktion bei Patienten mit stabiler koronarer Herzkrankheit</keyword>
</DOC>